Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
about
A prospective surveillance model for rehabilitation for women with breast cancerTreatment related impairments in arm and shoulder in patients with breast cancer: a systematic review.Cancer, physical activity, and exerciseImage-guided radiotherapy for cardiac sparing in patients with left-sided breast cancer.The burden of chronic diseases in a rural North Florida sample.Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC)Cardiotoxic heart failure in breast cancer survivors: a concept analysis.Long-term Toxicity of Cancer Treatment in Older PatientsBreast cancer survivorship symptom management: current perspective and future development.Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.At cancer diagnosis: a 'window of opportunity' for behavioural change towards physical activity. A randomised feasibility study in patients with colon and breast cancerCalcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy.The challenge of preserving cardiorespiratory fitness in physically inactive patients with colon or breast cancer during adjuvant chemotherapy: a randomised feasibility studyNo difference in dose distribution in organs at risk in postmastectomy radiotherapy with or without breast implant reconstruction.Cancer-related fatigue: implications for breast cancer survivors.Management of the axilla in early breast cancer patients in the genomic era.Cancer in heart disease patients: what are the limitations in the treatment strategy?Cardiovascular disease among breast cancer survivors: the call for a clinical vascular health toolbox.How do I follow patients with early breast cancer after completing adjuvant therapy.Current and emerging modalities for detection of cardiotoxicity in cardio-oncology.Comprehensive review on cardio-oncology: Role of multimodality imaging.Functional status and quality of life among breast cancer survivors with heart failure: results of the Medicare Health Outcomes Survey.3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study).Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities.Determinants of newly diagnosed comorbidities among breast cancer survivors.[Delayed effects of oncological therapy].Effects of a Translational Community-Based Multimodal Exercise Program on Quality of Life and the Influence of Start Delay on Physical Function and Quality of Life in Breast Cancer Survivors: A Pilot Study.Effects of a community-based multimodal exercise program on physical function and quality of life in cancer survivors: a pilot study.Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens.Competing risks of cancer mortality and cardiovascular events in individuals with multimorbidity.Prevalence of Cardiac Disease in Breast Cancer Patients at Time of Diagnosis Compared to the General Female Population in Germany
P2860
Q27010396-F3034632-0F37-4D8B-8EED-1ED124927DE3Q33590486-F23E89C1-09E3-4AFB-96EA-C530D0EE704AQ34004946-63DD7FAA-23B3-4BE6-91ED-34FBDE2D1537Q34229813-3CF5F86A-E5DF-4265-9244-09F4B6EC2267Q35003372-E1484AF6-69AE-4D82-AAF6-08974454C843Q35911581-3B37EB9A-93F9-4A12-9E06-229BCA9F2F0BQ36002576-07472CFA-38D7-41C6-9D6C-997A8B2ED04FQ36821673-06577F07-669F-401F-AF17-16FDB8E4B3B2Q36956837-F9DFB342-AD06-4CBE-A4B6-514CD4527FA6Q37266266-1954D8A3-8E83-4D1C-81F4-3C7D3CF13289Q37293242-D48A6BC6-8C52-455F-BB24-12BF4D80C891Q37350988-36358168-020E-4B0B-A824-83D4DAC96196Q37425506-92CE6E6A-7110-45E7-BE78-74946B585FF0Q37533230-3A5B45A5-9D7A-45A1-A00A-D8AAB49345E5Q38001375-A5EC1231-FF96-4488-A479-7ED3F8639DE2Q38061094-28A7F51D-C9EB-48DC-AD99-0F14BCC3BD8FQ38120092-1254DD3B-C76D-4C9F-A49E-008A55A6DDFCQ38163389-AA12B604-EC26-44A3-B4DF-97E1FD58A74DQ38172001-C96C2136-15B6-48F0-BFE1-3193B58E6DA5Q38559474-DE08B6C3-7253-4F86-939A-FDD038968DACQ38844387-040F0820-A422-4F27-875B-F19B6CB1FC70Q38919293-43BE6726-EBA8-4F29-8351-4D358B9EA006Q40497238-B1AD5EDE-A560-4F0F-977C-78BD677EEDEAQ42547157-456F0188-E3CE-4291-8A90-011F61E17AEEQ44197715-1F2604A7-C9FC-4FE6-ABA2-A375B9A3EC1AQ44239233-EE086CF9-37C6-421F-92AF-FD3BDA7CB7FDQ47633588-17BD060E-8BED-4B36-A8B5-D322F95982E9Q47756259-36433D09-FF45-48E6-AAEC-AB1AD391363FQ54967616-0AA36622-6E62-4872-969F-9885336D125EQ55018781-16948DD8-07BE-4CED-8E19-F2D0BA8BDD75Q57495761-02AD890A-B6D4-4797-8E37-9E60F80525D3
P2860
Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prospective surveillance and m ...... th in breast cancer survivors.
@en
type
label
Prospective surveillance and m ...... th in breast cancer survivors.
@en
prefLabel
Prospective surveillance and m ...... th in breast cancer survivors.
@en
P2093
P2860
P356
P1433
P1476
Prospective surveillance and m ...... lth in breast cancer survivors
@en
P2093
Anna L Schwartz
Joseph R Carver
Robert G Prosnitz
P2860
P304
P356
10.1002/CNCR.27462
P407
P433
P577
2012-04-01T00:00:00Z